These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38178138)

  • 1. The artificial amino acid change in the sialic acid-binding domain of the hemagglutinin neuraminidase of newcastle disease virus increases its specificity to HCT 116 colorectal cancer cells and tumor suppression effect.
    Jung BK; An YH; Jang SH; Jang JJ; Kim S; Jeon JH; Kim J; Song JJ; Jang H
    Virol J; 2024 Jan; 21(1):7. PubMed ID: 38178138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newcastle Disease Virus Establishes Persistent Infection in Tumor Cells
    Rangaswamy US; Wang W; Cheng X; McTamney P; Carroll D; Jin H
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28592535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-terminal truncation of the hemagglutinin-neuraminidase (HN) protein enhances the virulence and immunogenicity of Newcastle disease virus (NDV) vaccine strain V4.
    Ren X; Zeng Z; Shang Y; Yao L; Li L; Zhang W; Guo Y; Wang H; Zhang R; Shao H; Hu S; Luo Q; Wen G
    Arch Virol; 2023 Jul; 168(8):203. PubMed ID: 37418014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles virus fusion machinery activated by sialic acid binding globular domain.
    Talekar A; Moscona A; Porotto M
    J Virol; 2013 Dec; 87(24):13619-27. PubMed ID: 24109225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newcastle disease virus chimeras expressing the Hemagglutinin- Neuraminidase protein of mesogenic strain exhibits an enhanced anti-hepatoma efficacy.
    He J; Pan Z; Tian G; Liu X; Liu Y; Guo X; An Y; Song L; Wu H; Cao H; Yu D; Che R; Xu P; Rasoul LM; Li D; Yin J
    Virus Res; 2016 Aug; 221():23-9. PubMed ID: 27164362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of the highly conserved amino acids in the globular head and stalk region of the Newcastle disease virus HN protein in the membrane fusion process.
    Sun C; Wen H; Chen Y; Chu F; Lin B; Ren G; Song Y; Wang Z
    Biosci Trends; 2015 Feb; 9(1):56-64. PubMed ID: 25787910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of parainfluenza virus type 3 and Newcastle disease virus hemagglutinin-neuraminidase receptor binding: effect of receptor avidity and steric hindrance at the inhibitor binding sites.
    Porotto M; Murrell M; Greengard O; Lawrence MC; McKimm-Breschkin JL; Moscona A
    J Virol; 2004 Dec; 78(24):13911-9. PubMed ID: 15564499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumor effects of an oncolytic adenovirus expressing hemagglutinin-neuraminidase of Newcastle disease virus in vitro and in vivo.
    He D; Sun L; Li C; Hu N; Sheng Y; Chen Z; Li X; Chi B; Jin N
    Viruses; 2014 Feb; 6(2):856-74. PubMed ID: 24553109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct interaction of the molecular chaperone GRP78/BiP with the Newcastle disease virus hemagglutinin-neuraminidase protein plays a vital role in viral attachment to and infection of culture cells.
    Han C; Xie Z; Lv Y; Liu D; Chen R
    Front Immunol; 2023; 14():1259237. PubMed ID: 37920471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening and mechanistic study of key sites of the hemagglutinin-neuraminidase protein related to the virulence of Newcastle disease virus.
    Yan C; Liu H; Jia Y; Prince-Theodore DW; Yang M; Addoma Adam FE; Ren J; Cao X; Wang X; Xiao S; Zhang S; Yang Z
    Poult Sci; 2020 Jul; 99(7):3374-3384. PubMed ID: 32616231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncolytic Newcastle disease virus expressing chimeric antibody enhanced anti-tumor efficacy in orthotopic hepatoma-bearing mice.
    Wei D; Li Q; Wang XL; Wang Y; Xu J; Feng F; Nan G; Wang B; Li C; Guo T; Chen ZN; Bian H
    J Exp Clin Cancer Res; 2015 Dec; 34():153. PubMed ID: 26689432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tumor suppressive effect and apoptotic mechanism of TRAIL gene-containing recombinant NDV in TRAIL-resistant colorectal cancer HT-29 cells and TRAIL-nonresistant HCT116 cells, with each cell bearing a mouse model.
    Jung BK; An YH; Jang SH; Ryu G; Jung SB; Kim S; Kim CS; Jang H
    Cancer Med; 2023 Oct; 12(20):20380-20395. PubMed ID: 37843231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing environmental safety and cell-killing potential of oncolytic Newcastle Disease virus with modifications of the V, F and HN genes.
    de Graaf JF; van Nieuwkoop S; Bestebroer T; Groeneveld D; van Eijck CHJ; Fouchier RAM; van den Hoogen BG
    PLoS One; 2022; 17(2):e0263707. PubMed ID: 35139115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NDV targets the invasion pathway in malaria parasite through cell surface sialic acid interaction.
    Neog S; Vinjamuri SR; Vijayan K; Kumar S; Trivedi V
    FASEB J; 2024 Aug; 38(15):e23856. PubMed ID: 39092913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agglutination-separation reactions of red blood cells sensitized with Newcastle disease virus: quantities, agglutination characteristics, and serology of altered virus and HN spikes released following neuraminidase reactivation.
    Graves IL
    Vet Res; 2001; 32(5):475-89. PubMed ID: 11592617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, Synthesis, and Antiviral Evaluation of Sialic Acid Derivatives as Inhibitors of Newcastle Disease Virus Hemagglutinin-Neuraminidase: A Translational Study on Human Parainfluenza Viruses.
    Rota P; La Rocca P; Bonfante F; Pagliari M; Piccoli M; Cirillo F; Ghiroldi A; Franco V; Pappone C; Allevi P; Anastasia L
    ACS Infect Dis; 2023 Mar; 9(3):617-630. PubMed ID: 36848501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the amino acids residues involved in hemagglutinin-neuraminidase of Newcastle disease virus binding to sulfated Chuanmingshen violaceum polysaccharides.
    Song X; Liu L; Hu W; Liang X; He C; Yin L; Ye G; Zou Y; Li L; Tang H; Jia R; Yin Z
    Poult Sci; 2021 Aug; 100(8):101255. PubMed ID: 34198092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing the sialic acid binding site of the hemagglutinin-neuraminidase of Newcastle disease virus: identification of key amino acids involved in cell binding, catalysis, and fusion.
    Connaris H; Takimoto T; Russell R; Crennell S; Moustafa I; Portner A; Taylor G
    J Virol; 2002 Feb; 76(4):1816-24. PubMed ID: 11799177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α2,6-linked sialic acid serves as a high-affinity receptor for cancer oncolytic virotherapy with Newcastle disease virus.
    Li Q; Wei D; Feng F; Wang XL; Li C; Chen ZN; Bian H
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2171-2181. PubMed ID: 28687873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic Newcastle disease virus expressing the co-stimulator OX40L as immunopotentiator for colorectal cancer therapy.
    Tian L; Liu T; Jiang S; Cao Y; Kang K; Su H; Ren G; Wang Z; Xiao W; Li D
    Gene Ther; 2023 Feb; 30(1-2):64-74. PubMed ID: 34602608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.